English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/226398
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

AuthorsMerino, Beatriz; Fernández-Díaz, C. CSIC ORCID; Parrado-Fernández, Cristina; González-Casimiro, Carlos M.; Postigo-Casado, Tamara; Lobatón, Carmen D.; Leissring, Malcolm A.; Cózar-Castellano, Irene CSIC ORCID CVN; Perdomo, Germán
KeywordsInsulin-degrading enzyme
High-fat diet
Hepatic insulin resistance
Insulin receptor
Glucose transporters
Issue DateOct-2020
CitationMetabolism: Clinical and Experimental 113: 154352 (2020)
AbstractThe insulin-degrading enzyme (IDE) is a metalloendopeptidase with a high affinity for insulin. Human genetic polymorphisms in Ide have been linked to increased risk for T2DM. In mice, hepatic Ide ablation causes glucose intolerance and insulin resistance when mice are fed a regular diet. [Objective]: These studies were undertaken to further investigate its regulatory role in glucose homeostasis and insulin sensitivity in diet-induced obesity. [Methods]: To this end, we have compared the metabolic effects of loss versus gain of IDE function in mice fed a high-fat diet (HFD). [Results]: We demonstrate that loss of IDE function in liver (L-IDE-KO mouse) exacerbates hyperinsulinemia and insulin resistance without changes in insulin clearance but in parallel to an increase in pancreatic β-cell function. Insulin resistance was associated with increased FoxO1 activation and a ~2-fold increase of GLUT2 protein levels in the liver of HFD-fed mice in response to an intraperitoneal injection of insulin. Conversely, gain of IDE function (adenoviral delivery) improves glucose tolerance and insulin sensitivity, in parallel to a reciprocal ~2-fold reduction in hepatic GLUT2 protein levels. Furthermore, in response to insulin, IDE co-immunoprecipitates with the insulin receptor in liver lysates of mice with adenoviral-mediated liver overexpression of IDE. [Conclusions]: We conclude that IDE regulates hepatic insulin action and whole-body glucose metabolism in diet-induced obesity via insulin receptor levels.
Description© 2020 The Authors.
Publisher version (URL)http://dx.doi.org/10.1016/j.metabol.2020.154352
Appears in Collections:(IBGM) Artículos
Files in This Item:
File Description SizeFormat 
Hepatic_Merino_Art2020.pdf2,75 MBUnknownView/Open
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.